Avalo Therapeutics Inc
(AVTX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 06-2019 | 03-2019 | 12-2018 | 09-2018 | 06-2018 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -13,677 | -7,454 | -40,053 | -34,494 | -9,890 |
| Depreciation Amortization | 3,693 | 1,121 | 6,717 | 5,457 | 4,142 |
| Income taxes - deferred | 19 | 6 | -17 | -48 | 24 |
| Accounts receivable | 297 | 439 | -223 | -74 | -373 |
| Accounts payable and accrued liabilities | -1 | -197 | 83 | 172 | 1,641 |
| Other Working Capital | -185 | 2,428 | 8,708 | 6,724 | 3,632 |
| Other Operating Activity | 15 | 535 | 21,656 | 21,110 | 211 |
| Operating Cash Flow | $-9,839 | $-3,122 | $-3,128 | $-1,152 | $-614 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -257 | -166 | -564 | -65 | -26 |
| Other Investing Activity | 0 | 0 | 1,430 | 1,430 | 0 |
| Investing Cash Flow | $-257 | $-166 | $866 | $1,365 | $-26 |
| Cash Flows From Financing Activities | |||||
| Debt Repayment | -49 | -24 | N/A | N/A | N/A |
| Common Stock Issued | 9,360 | 94 | 1,156 | 4,374 | 399 |
| Other Financing Activity | -397 | 8,747 | 9,248 | -137 | 0 |
| Financing Cash Flow | $8,914 | $8,817 | $10,404 | $4,237 | $399 |
| Beginning Cash Position | 10,747 | 10,747 | 2,606 | 2,606 | 2,606 |
| End Cash Position | 9,565 | 16,276 | 10,747 | 7,055 | 2,364 |
| Net Cash Flow | $-1,182 | $5,530 | $8,141 | $4,450 | $-241 |
| Free Cash Flow | |||||
| Operating Cash Flow | -9,839 | -3,122 | -3,128 | -1,152 | -614 |
| Capital Expenditure | -257 | -166 | -564 | -65 | -26 |
| Free Cash Flow | -10,096 | -3,288 | -3,693 | -1,218 | -640 |